Sedation, shivering, and agitation control
›Pharmacologic control of agitation and shivering
›Benzodiazepines
›Lorazepam IV 1 mg to 2 mg
›Repeat every 5 to 10 minutes as needed
›Max dose individualized by respiratory status
›Diazepam IV 5 mg to 10 mg
›Repeat every 5 to 10 minutes as needed
›Midazolam IV 2 mg to 5 mg
›Repeat every 5 minutes as needed
›Evidence level
›Shivering reduction to facilitate cooling
›Expert consensus ACEP Level C
›If intubated sedation strategies
›Propofol infusion
›Initiate 5 mcg/kg/min
›Titrate 5 mcg/kg/min to 10 mcg/kg/min every 5 minutes
›Typical range 5 mcg/kg/min to 50 mcg/kg/min
›Hypotension monitoring
›Dexmedetomidine infusion
›Initiate 0.2 mcg/kg/hour
›Titrate 0.1 mcg/kg/hour every 15 to 30 minutes
›Max 1.5 mcg/kg/hour
›Bradycardia monitoring
Airway and ventilation management
›Respiratory support
›Oxygen therapy
›Nasal cannula or mask to maintain saturation targets
›Intubation considerations
›Rapid sequence induction with hemodynamic awareness
›Avoid succinylcholine if severe hyperkalemia from rhabdomyolysis suspected
›Post intubation temperature monitoring with esophageal probe
›Circulatory support
›Isotonic crystalloid bolus
›500 mL to 1000 mL initial bolus adult
›Repeat based on perfusion and ultrasound
›Vasopressor strategy
›Norepinephrine infusion
›Initiate 0.05 mcg/kg/min
›Titrate every 2 to 5 minutes to MAP target
›Typical range 0.05 mcg/kg/min to 0.5 mcg/kg/min
›MAP target
›>= 65 mmHg in shock
›Higher targets individualized in chronic hypertension
›Seizure control
›Benzodiazepines first line
›Lorazepam IV 0.1 mg/kg
›Max single dose 4 mg
›Repeat once if needed
›Second line antiseizure therapy
›Levetiracetam IV 60 mg/kg
›Max 4500 mg
›Infuse over 10 to 15 minutes
›Refractory seizure escalation
›Continuous infusion sedation in ICU
Rhabdomyolysis and renal protection
›Rhabdomyolysis management
›Fluid strategy
›Isotonic crystalloid to support renal perfusion
›Urine output target
›1 mL/kg/hour to 2 mL/kg/hour
›Electrolyte monitoring
›Potassium trending
›Calcium trending
›Phosphate trending
›Renal replacement therapy triggers
›Refractory hyperkalemia
›Severe acidosis
›Volume overload with respiratory compromise
›Uremic complications
›Hemostatic management
›DIC supportive care
›Platelet transfusion if bleeding with thrombocytopenia
›Cryoprecipitate for low fibrinogen with bleeding
›Plasma for active bleeding with prolonged INR
›Evidence level
›Standard critical care consensus
›Expert consensus ACEP Level C
Temperature adjuncts and contraindicated therapies
›Adjunct and avoidance list
›Antipyretics
›No role in heat stroke
›Hepatotoxicity risk with acetaminophen
›Bleeding and renal risk with NSAIDs
›Dantrolene
›Not recommended for heat stroke
›Reserved for malignant hyperthermia
›Antibiotics
›Only if infection suspected based on clinical context
Evidence levels and guideline signals
›Evidence summary
›Rapid active cooling
›Strong recommendation Class I
›Expert consensus ACEP Level C
›Ice water immersion for exertional heat stroke
›Preferred when feasible
›Guideline supported in wilderness and sports medicine consensus
›Evaporative cooling for classic heat stroke
›Effective alternative when immersion not feasible
›Expert consensus recommendation